Navigation Links
Jennerex and Transgene Announce Presentation of Phase 1 Data Demonstrating that JX-594 Administration Targets Tumor Vasculature
Date:4/5/2011

lable on the internet at www.transgene.fr

About Green Cross Corp.:

Green Cross Corp. is a publicly traded and leading Korean biopharmaceutical company specialized in development and commercialization of vaccines, plasma-derivatives, recombinant proteins and therapeutic antibodies in oncology and infectious diseases. Green Cross Corp. has been collaborating with Jennerex in Korea since 2006 to jointly conduct the Phase 1 and 2 clinical trials in patients with liver cancer. Additional information about Green Cross Corp. is available on the internet at www.greencross.com.

Cautionary note for Transgene regarding forward-looking statements

This press release contains forward-looking statements referring to the joint clinical testing and development and commercial potential of JX-594. Clinical testing and successful product development and commercialization depend on a variety of factors, including the timing and success of future patient enrolment, the risk of unanticipated adverse patient reactions, regulatory approval and the level of demand for the product by the medical community. Results from future studies with more data may show less favorable outcomes than prior studies, and there is no certainty that product candidates will ever demonstrate adequate therapeutic efficacy or achieve regulatory approval or commercial success. In addition, forward-looking statements regarding product development, testing and marketing costs are by the nature subject to uncertainties as a result of unforeseen difficulties and expenses which may arise, and future product development costs may exceed current expectations.  For further information on the risks and uncertainties involved in the testing and development of Transgene's product candidates, see Transgene's Document de Reference on file with the French Autorite des marches financiers on its w
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors
2. Jennerex Names Ursula Fritsch, PharmD, as Vice President, Regulatory Affairs
3. Jennerex and Transgene Announce Initiation of Clinical Trial of Intravenous JX-594 in Patients With Refractory Metastatic Colorectal Cancer
4. Jennerex Names Dr. Mark P. Backer as Senior Vice President of Technical Operations
5. Jennerex Appoints Lara Longpre to Chief Operating Officer
6. Jennerex Appoints Gregory W. Schafer as Chief Financial Officer
7. Jennerex Announces Presentations at Upcoming Conferences
8. Jennerex, Inc. Receives EMEA Orphan Drug Designation for JX-594 for the Treatment of Hepatocellular Carcinoma
9. Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research
10. Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer
11. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 2015   DocResponse was ranked the ... a peer-reviewed study , "Evaluation of symptom ... published in the July issue of The British ... Medical School researchers determined that performance of online ... correct diagnosis first in standardized patient evaluations more ...
(Date:7/27/2015)... , July 27, 2015 Research and ... the "Intraoperative Imaging Market by Type (Intraoperative CT, ... Europe, Asia-Pacific, ROW) - Global Forecast to 2019" ... is expected to reach a value of $2.1 Billion ... CAGR of 3.5% during the forecast period. ...
(Date:7/27/2015)... 2015 EMD Millipore , the ... of Darmstadt, Germany , today ... pegylation services to customers developing protein-based therapeutics and ... collaboration includes feasibility studies, process and analytical development, ... for pilot and subsequent commercial scale. ...
Breaking Medicine Technology:Harvard Study Finds DocResponse Most Accurate Medical Symptom Checker/Diagnostics Application 2Harvard Study Finds DocResponse Most Accurate Medical Symptom Checker/Diagnostics Application 3Global Intraoperative Imaging (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) Market Forecasts & Trends 2015-2019 2EMD Millipore Adds Protein Pegylation to Portfolio of Services for Biopharmaceutical Industry through Collaboration with celares GmbH 2EMD Millipore Adds Protein Pegylation to Portfolio of Services for Biopharmaceutical Industry through Collaboration with celares GmbH 3
... Laboratories Inc., a specialty pharmaceutical and diagnostic company, today ... Vice President and Chief Medical Officer. Dr. ... in the medical field.  He comes most recently from ... Medical Director of Global Businesses since 2005. In this ...
... Apelon, Inc ., a leading provider of terminology ... selected by Canada Health Infoway ( Infoway ) ... deployment of SNOMED CT across Canada. SNOMED ... Apelon,s Distributed Terminology Systems (DTS) vocabulary server, TermWorks® ...
Cached Medicine Technology:Prometheus Announces New Chief Medical Officer 2Apelon Provides Products and Services to Support Canadian Healthcare Data Standardization 2
(Date:7/27/2015)... (PRWEB) , ... July 28, 2015 , ... The ... 2015-2016 inductee into the NAPW VIP Woman of the Year Circle. She is recognized ... over 200 operating Local Chapters, NAPW is the nation’s leading networking organization exclusively for ...
(Date:7/27/2015)... ... 27, 2015 , ... The heroin epidemic is affecting the Charlotte in North ... 7th. The rate for heroin usage has continued to climb around the country in ... less expensive alternative for those with an addiction to prescription opiate medications. According to ...
(Date:7/27/2015)... ... July 27, 2015 , ... In a piece published ... side of plastic surgery and explained why people should not shy away from their ... the excesses of the few and celebrate it for the modern wonder that it ...
(Date:7/27/2015)... ... July 27, 2015 , ... Eugene Batelli, D.P.M., F.A.C.F.A.S, just recently performed ... patient is high-end athlete, whose accomplishments include running in 27 triathlons and swimming the ... which was diagnosed as tendinitis. I did an ultrasound and found a partial ...
(Date:7/27/2015)... ... July 27, 2015 , ... Send Word Now, ... mobile collaboration, announced today the latest software release for its award-winning ... feature enhancements. , This software release gives the widely used online application a ...
Breaking Medicine News(10 mins):Health News:NAPW Inducts Jane Simmons, Counseling Intern at Omar Bradley Middle School of the Northeast Independent School District , Into its VIP Woman of the Year Circle 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 3Health News:Recent Op-Ed Defending Plastic Surgery Highlights the Personal Side of Cosmetic Procedures, says Beverly Hills Physicians 2Health News:NJ Top Docs Presents, Dr. Eugene Batelli of Metropolitan Ankle & Foot Care Specialists 2Health News:NJ Top Docs Presents, Dr. Eugene Batelli of Metropolitan Ankle & Foot Care Specialists 3Health News:Send Word Now Announces Release of New User Interface for its Award-Winning Mass Notification Service 2
... for out-of-hospital cardiac arrest, an analysis of data indicates their ... in an improved rate of survival, according to a study ... study is being released early online because it will be ... of automated external defibrillators (AEDs) has been proposed as a ...
... blood biomarker cardiac troponin T (cTnT), a cardiac-specific protein, using ... heart failure or cardiovascular death in older adults, according to ... of JAMA . The study is being released early ... Association,s annual meeting. "Older adults comprise the majority of ...
... be caused by the gradual accumulation in the brain of amyloid-beta ... formed from a protein known as APP, which is found in ... study for the disease does not distinguish between the different ... Journal of Biological Chemistry , show that amyloid beta peptide is ...
... (HealthDay News) -- Could cholesterol deposits on or around ... preliminary Danish study suggests that the deposits could point ... and early death. Half of patients with such ... cholesterol levels. The research team therefore believes that buildup ...
... Reporter , MONDAY, Nov. 15 (HealthDay News) -- Omega-3 fatty ... a type of irregular heartbeat that can cause stroke, new ... don,t work for most patients with AF [atrial fibrillation]," said ... in the Dec. 1 issue of the Journal of ...
... News) -- As children mature, increased synchronization between specific ... and others, a new study suggests. This includes ... University Medical Center researchers used functional MRI to examine ... comprise what,s known as the default-mode network (DMN). ...
Cached Medicine News:Health News:Use of AEDs in hospitals for cardiac arrest not linked with improved survival 2Health News:Use of AEDs in hospitals for cardiac arrest not linked with improved survival 3Health News:Biomarker may be able to help predict risk of heart failure, cardiovascular death 2Health News:Biomarker may be able to help predict risk of heart failure, cardiovascular death 3Health News:'Magic number' 695 opens up new areas for Alzheimer's research 2Health News:Cholesterol on Eyelids Might Point to Heart Risk 2Health News:Omega-3 Supplements Won't Fight Irregular Heartbeat 2Health News:Omega-3 Supplements Won't Fight Irregular Heartbeat 3Health News:Brain Organizes Itself for Introspection as Children Age: Study 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: